Published Date : Apr 08, 2016
Defibrillator devices are used to depolarize critical part of heart muscle, thereby helping to restore normal heart rhythm. If defibrillation and cardiopulmonary resuscitation (CPR) is given to SCA victims within 5 to 12 minutes of cardiac arrest, the chances of saving his life considerably increases. The increasing incidence of cardiovascular disease and rapidly developing healthcare infrastructure, particularly in developing countries, are the key factors aiding the growth of the Middle East and Africa defibrillator market.
Defibrillators Market in the Middle East and Africa to Exhibit 7.6% CAGR, during 2014-2020
According to a report published by Transparency Market Research, the Middle East and Africa market for defibrillators, which in 2013 stood at US$209.6 mn, is anticipated to reach US$347.8 mn by the end of 2020. If the figures hold true, the market will exhibit a CAGR of 7.6% between 2014 and 2020.
A defibrillator device is used to give electric shocks during the treatment of life threatening cardiac arrhythmias. The device is capable of giving electric shocks with energy between 40 and 400 Joule. These shocks are mainly given to heart muscles to re-establish normal rhythm and contraction of heart by terminating arrhythmia.
Lack of Awareness about Defibrillators Inhibits Market Growth in Middle East and Africa
Despite witnessing positive opportunities in the Middle East and Africa, inadequate awareness about operating these devices and unfavorable government policies are inhibiting the growth of the defibrillators market in the region.
The Middle East and Africa defibrillators market can be segmented on the basis of end user, product type, and geography. In terms of type, the market is bifurcated into advanced life support (ALS) and automated external defibrillators (AEDs). On the basis of end user, the market has been segmented into hospitals, public access, business workplaces, and emergency medical services. Regionally, the market can be segmented into the Middle East, which include Jordon, Saudi Arabia, UAE, Qatar, and Rest of the Middle East and Africa, which encompasses South Africa, Algeria, Egypt, and Rest of Africa.
Companies Rely on Local Representatives for Distribution Process
A majority of companies in the Middle East and Africa defibrillators market are reluctant to invest on developing a distribution network of their own. This is primarily due to the lack of awareness regarding defibrillators and CPR products. Also lack of demand in the region for the products also discourages the enterprises operating in the market. Hence, these companies generally rely on local representatives to facilitate their distribution process.
Some of the companies operating in the region are Physio-Control, Inc., Nihon Kohden Corporation, Zoll Medical Corporation, Philips Healthcare, and others.